Cargando…

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells

BACKGROUND: Alanine‐serine‐cysteine transporter 2 (ASCT2), a major glutamine transporter, is essential for cell growth and tumor development in a variety of cancers. However, the clinicopathological significance and pathological role of ASCT2 in OSCC (oral squamous cell carcinoma) lesions remain unc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yijun, Li, Wei, Ling, Zihang, Hu, Qinchao, Fan, Zhen, Cheng, Bin, Tao, Xiaoan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221297/ https://www.ncbi.nlm.nih.gov/pubmed/32162845 http://dx.doi.org/10.1002/cam4.2965

Ejemplares similares

Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018)

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018)

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
por: Marshall, A D, et al.
Publicado: (2017)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
por: Hara, Yuta, et al.
Publicado: (2019)

Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019)

Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
por: Wang, Qian, et al.
Publicado: (2015)

Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism
por: Dong, J, et al.
Publicado: (2017)

Rational design of ASCT2 inhibitors using an integrated experimental-computational approach
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2021)

Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models
por: Schulte, Michael L., et al.
Publicado: (2018)

Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells
por: Wang, Wenbin, et al.
Publicado: (2022)

NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2
por: Ding, Mingchao, et al.
Publicado: (2020)

ASCT2 is the primary serine transporter in cancer cells
por: Conger, Kelly O., et al.
Publicado: (2023)

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
por: Scopelliti, Amanda J, et al.
Publicado: (2018)

The Treatment of Multiple Myeloma Patients Not Eligible for Asct
por: Richardson, Paul, et al.
Publicado: (2010)

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
por: Sun, Hong-Wei, et al.
Publicado: (2016)

Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
por: Lohavanichbutr, Pawadee, et al.
Publicado: (2012)

Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression
por: Kontos, Christos K.
Publicado: (2015)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion
por: Kamarajan, Pachiyappan, et al.
Publicado: (2010)

Voltage-dependent processes in the electroneutral amino acid exchanger ASCT2
por: Zander, Catherine B., et al.
Publicado: (2013)

Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
por: Polet, Florence, et al.
Publicado: (2016)

ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
por: Zhang, Ze, et al.
Publicado: (2019)

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells
por: Yu, Wei, et al.
Publicado: (2022)

A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer
por: Lyu, Xiao-Dan, et al.
Publicado: (2023)

4sc‐202 and Ink‐128 cooperate to reverse the epithelial to mesenchymal transition in OSCC
por: Yang, Xi, et al.
Publicado: (2021)

Breastfeeding and childhood cancer risks: OSCC data
por: Lancashire, R J, et al.
Publicado: (2003)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC
por: Luo, Yanwei, et al.
Publicado: (2020)

Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
por: Gimsing, P, et al.
Publicado: (2015)

C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC
por: Chen, Xiyan, et al.
Publicado: (2017)

Impact of ERCC2 Gene Polymorphisms on OSCC Susceptibility and Clinical Characteristics
por: Tejasvi, ML Avinash, et al.
Publicado: (2020)

The Challenges of OSCC Diagnosis: Salivary Cytokines as Potential Biomarkers
por: Roi, Alexandra, et al.
Publicado: (2020)

Exosomal cargoes in OSCC: current findings and potential functions
por: Zhao, Chengzhi, et al.
Publicado: (2020)

Identification of therapeutically potential targets and their ligands for the treatment of OSCC
por: Kumari, Pratima, et al.
Publicado: (2022)

Metastases of OSCC Based on Oral Lichen Ruber Planus
por: Obermeier, Katharina Theresa, et al.
Publicado: (2023)

Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC
por: Grimm, Martin, et al.
Publicado: (2015)

Identification and preliminary study of a novel interacting protein SCRIB with fibroblast activation protein in OSCC: SCRIB interacts with fibroblast activation protein in OSCC
por: Liu, Shuyan, et al.
Publicado: (2023)

Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
por: Bröer, Angelika, et al.
Publicado: (2018)

Heterologous avian system for quantitative analysis of Syncytin-1 interaction with ASCT2 receptor
por: Štafl, Kryštof, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uthdsbjld17ssspjsedlijnaou